Our Vision To be a leading international science-based regulator to protect and promote public health. Our Mission Protecting the community through regulations and effective controls to ensure the safety of food, drugs, medical devices, cosmetics, pesticides and feed. Authoritys main objectives The main purpose of the SFDA establishment is to regulate, oversee, and control food, drug, medical devices, as well as to set mandatory standard specifications thereof, whether they are imported or locally manufactured. The control and/or testing activities can be conducted in the SFDA or other agencys laboratories. Moreover, the SFDA is in charge of consumers awareness on all matters related to food, drug and medical devices and all other products and supplies. The main objectives of SFDA can be outlined as follows: Observe the safety, security, and effectiveness of food and drug for humans and animal. Observe the safety of complementary biological and chemical substances, cosmetics and pesticides. Observe the safety of medical devices and its impact on public health. Ensure accuracy and safety of medical and diagnostic devices. Launch clear policies and procedures for food and drug, and plan to achieve and implement these policies. Conduct research and applied studies to identify health problems, their causes, determine its impact on public, with the consideration of methods for research / studies evaluation. The authority shall establish scientific bases for awareness and consulting services and executive programs in the fields of food and drug. This can be accomplished through the recruitment of experts and specialists or through the partnership with research bodies such as King Abdulaziz City for Science and Technology (KACST) and/or universities research centers. Control and supervise licenses procedures for food, drugs and medical devices factories. Disseminate and exchange information with local and international scientific and legal agencies, and setting up a database for food and drug. The strategic Plan Saudi Food and Drug Authority launch the 3rd strategy (2018-2022). To review please The strategic Plan